Related Experiment Video
Updated: Jul 14, 2026
11:06
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Acute hepatotoxicity: a predictive model based on focused illumina microarrays
Nadine Zidek1, Juergen Hellmann, Peter-Juergen Kramer
1Molecular Toxicology, Institute of Toxicology, Merck KGaA, Darmstadt, Germany.
Summary
Toxicogenomics using gene expression profiling can accurately predict drug-induced liver toxicity. A focused gene microarray successfully identified hepatotoxic compounds early in drug development.
Area of Science:
- Toxicology
- Genomics
- Drug Development
Background:
- Drug-induced hepatotoxicity poses significant challenges in pharmaceutical development.
- Toxicogenomics offers a promising approach for early toxicity screening.
Purpose of the Study:
- To establish a predictive screening system for acute hepatotoxicity using gene expression profiles.
- To identify potential marker genes indicative of liver toxicity.
Main Methods:
- A bead-based Illumina oligonucleotide microarray with 550 liver-specific genes was utilized.
- Rats were administered known hepatotoxic and non-hepatotoxic compounds at varying doses.
- Gene expression profiles and histopathological changes were analyzed at 6, 24, and 72 hours post-treatment.
Main Results:
- Gene expression profiling accurately discriminated hepatotoxic from non-hepatotoxic compounds 24 hours after high-dose treatment.
- Sixty-four potential marker genes were identified, reflecting typical hepatotoxicity responses.
- The system correctly predicted toxicity for two unknown test compounds.
Conclusions:
- Focused gene microarrays are effective for classifying compounds regarding toxicity prediction.
- Identified genes and pathways may aid in early hepatotoxicity characterization and prediction.
- This toxicogenomic approach supports early toxicity screening in drug development.
